Aludrone; N-Isopropylnoradrenalone; 1-(3,4-dihydroxyphenyl)-2-(propan-2-ylamino)ethanone; S 35179; ACETOPHENONE, 3',4'-DIHYDROXY-2-(ISOPROPYLAMINO)-; 1-(3,4-DIHYDROXYPHENYL)-2-[(1-METHYLETHYL)AMINO]ETHAN-1-ONE; UNII-299T6A9WRP; 299T6A9WRP; CHEMBL598662; 1-(3,4-Dihydroxyphenyl)-2-((1-methylethyl)amino)ethan-1-one; 1-(3,4-DIHYDROXYPHENYL)-2-((1-METHYLETHYL)AMINO)ETHANONE; EINECS 204-461-0; NSC 163353; BRN 2105828; 1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]ethanone; MLS-0315678.0001; 3,4-Dihydroxy-alpha-isopropylaminoacetophenone; 3',4'-Dihydroxy-2-(isopropylamino)acetophenone; 1-(3,4-dihydroxyphenyl)-2-(propan-2-ylamino)ethanone;hydrochloride; Ethanone, 1-(3,4-dihydroxyphenyl)-2-((1-methylethyl)amino)-; 4-14-00-00835 (Beilstein Handbook Reference); SCHEMBL9768178; 4-(isopropylaminoacetyl)catechol; BDBM46041; cid_2830496; CTK4B2284; DTXSID90153099; BBL029136; NSC163353; STL372881; ZINC53193262; AKOS015955777; MCULE-3317742925; NSC-163353; Isoprenaline EP Impurity A; Isoproterenone; ST50977324; Acetophenone,4'-dihydroxy-2-(isopropylamino)-; 3,4-Dihydroxy-.alpha.-isopropylaminoacetophenone; A804709; 1-(3,4-dihydroxyphenyl)-2-(isopropylamino)ethanone; 3',4'-Dihydroxy-alpha-(isopropylamino)acetophenone; Ethanone,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]-; 1-(3,4-DIHYDROXY-PHENYL)-2-ISOPROPYLAMINO-ETHANONE; 1-[3,4-bis(oxidanyl)phenyl]-2-(propan-2-ylamino)ethanone; 1-(3,4-dihydroxyphenyl)-2-[(methylethyl)amino]ethan-1-one; Ethanone,1-(3,4-dihydroxyphenyl)-2-[(1-methylethyl)amino]-; 1-(3,4-dihydroxyphenyl)-2-(isopropylamino)ethanone;hydrochloride; 1-(3,4-dihydroxyphenyl)-2-[(propan-2-yl)amino]ethan-1-one, 3; 1-[3,4-bis(oxidanyl)phenyl]-2-(propan-2-ylamino)ethanone;hydrochloride; Ethanone, 1-(3,4-dihydroxyphenyl)-2-((1-methylethyl)amino)- (9CI)